Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Dorota Matecka
Introduction
Dorota Matecka is a notable inventor based in Washington, DC. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release derivatives that target the dopamine transporter. His work has implications for treating conditions related to dopamine reuptake inhibitors.
Latest Patents
Dorota Matecka holds a patent for "Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use." This invention provides sustained-release derivatives that can effectively bind the dopamine transporter, offering potential therapeutic benefits against substances like cocaine and methamphetamine. The patent highlights the pharmaceutical compositions and methods of using these derivatives to achieve desired effects.
Career Highlights
Dorota Matecka is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution underscores his commitment to advancing medical science and improving public health through innovative research.
Collaborations
Throughout his career, Dorota has collaborated with esteemed colleagues, including Richard B Rothman and Kenner C Rice. These partnerships have likely enriched his research and contributed to the success of his inventions.
Conclusion
Dorota Matecka's innovative work in the pharmaceutical field exemplifies the impact of targeted research on public health. His contributions continue to pave the way for advancements in treatment options for various conditions.